VEURX Vanguard European Stock Investor Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

The investment seeks to track the performance of a benchmark FTSE Developed Europe All Cap Index that measures the investment return of stocks issued by companies located in the major markets of the Pacific region. The fund employs an indexing investment approach designed to track the performance of the FTSE Developed Europe All Cap Index, a market-capitalization weighted index that is made up of common stocks of companies located in European countries. Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the target Index.

The average market capitalization across the Vanguard European Stock Investor MF is 241.13B. The market cap for tickers in the group ranges from 3.51M to 741.15B. ASML holds the highest valuation in this group at 741.15B. The lowest valued company is NOVN at 3.51M.

The average weekly volume growth across all stocks in the Vanguard European Stock Investor MF was -1%. For the same stocks of the MF, the average monthly volume growth was 15% and the average quarterly volume growth was -22%